Author:
Lougaris Vassilios,Plebani Alessandro
Reference7 articles.
1. Bain G, Robanus Maandag EC, Izon DJ, Amsen D, Kruisbeek AM, Weintraub BC, Krop I, Schlissel MS, Feeney AJ, van Roon M, van der Valk M, te Riele HPJ, Berns A, Murre C. E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangement. Cell. 1994;79:885–1994.
2. Bartholdy B, Matthias P. Transcriptional control of B cell development and function. Gene. 2004;327:1–23.
3. Boisson B, Wang YD, Bosompem A, Lim A, Kochetkov T, Tangye SG, Casanova JL, Conley ME. A recurrent dominant negative E47 mutation causes agammaglobulinemia and BCR-B cells. J Clin Invest. 2013;123:4781–5.
4. Conley ME, Cooper MD. Genetic basis of abnormal B cell development. Curr Opin Immunol. 1998;10(4):339–406.
5. Dobbs AK, Bosompem A, Coustan-Smith E, Tyerman G, Saulsburry FT, Conley ME. Agammaglobulinemia associated with BCR-Bcells and enhanced expression of CD19. J Clin Invest. 2011;118:1828–37.